Development of an Accessible Cognitive Behavioral Therapy Digital Therapeutic for Individuals With Long COVID

Sponsor
Toivoa Inc
Study ID
NCT07714889
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
22 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Rauha® Digital Therapeutic Platform (Toivoa-004) — DEVICE
    A coach-delivered, WCAG 2.2 AA-accessible digital therapeutic targeting anxiety and depression symptom management in adults with clinically documented Long COVID. The platform integrates evidence-based behavioral health content delivered via the Rauha® Coach application.

Study Details

This study will evaluate Toivoa-004 as an experimental digital therapeutic for persons with Long COVID suffering from anxiety or depression. This study will evaluate the completion rates of the Toivoa-004 program and survey the user's experience upon completion. Changes in anxiety and depression scores will be monitored during the study.

Key Dates

First listed
Jul 20, 2026
Start date
Jul 31, 2026
Status verified
Jun 2026
Primary completion
Sep 30, 2026
Completion
Sep 30, 2026

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY

Arms

  • Experimental: Toivoa-004

Primary Outcome Measure

Proportion of active users at Week 12 [ Time Frame: 12 weeks ]

Central Contacts

Find similar trials

Nationwide
Depression trialsCOVID-19 / long COVID trialsPsychiatry trialsMental health trialsBehavioral health trialsInfectious disease trials

Related Studies